Prevalence of non-communicable diseases and risk factors of pre-eclampsia/eclampsia in four local government areas in Nigeria: a cross-sectional study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
09 10 2023
Historique:
medline: 13 10 2023
pubmed: 12 10 2023
entrez: 9 10 2023
Statut: epublish

Résumé

To assess the prevalence of non-communicable diseases (NCDs) and risk factors associated with pre-eclampsia and eclampsia (PE/E) in women of reproductive age (WRA) in Nigeria. A cross-sectional survey was administered to the entire study population. In the point-of-care testing, physical and biochemical measurements were taken in a subset of the participants. The study was conducted in the Ikorodu and Alimosho local government areas (LGAs) in Lagos and the Abuja Municipal Area Council and Bwari LGAs in the Federal Capital Territory. Systematic random sampling was used to randomly select and recruit 639 WRA (aged 18-49 years) between May 2019 and June 2019. Prevalence of select NCDs (hypertension or raised blood pressure, diabetes or raised blood sugar levels, anaemia, truncal obesity and overweight/obesity) and risk factors associated with PE/E (physical activity, fruit and vegetable consumption, alcohol consumption and smoking). The prevalence of raised blood pressure measured among the WRA was 36.0% (95% CI 31.3% to 40.9%). Approximately 10% (95% CI 7.2% to 13.4%) of participants had raised blood sugar levels. About 19.0% (95% CI 15.3% to 23.2%) of the women had moderate or severe anaemia. Excluding WRA who were pregnant, 51.9% (95% CI 45.7% to 58.0%) of the women were either overweight or obese based on their body mass index. Approximately 58.8% (95% CI 53.8% to 63.6%) of WRA surveyed reported three to five risk factors for developing NCDs and PE/E in future pregnancies. The study identified a high prevalence of NCDs and associated PE/E risk factors in surveyed women, signifying the importance of early detection and intervention for modifiable NCD and associated PE/E risk factors in WRA. Further research is necessary to assess the national prevalence of NCDs.

Identifiants

pubmed: 37813536
pii: bmjopen-2023-071652
doi: 10.1136/bmjopen-2023-071652
pmc: PMC10565324
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e071652

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Niger J Clin Pract. 2020 Jul;23(7):889-896
pubmed: 32620715
BJOG. 2016 May;123(6):928-38
pubmed: 25974281
Public Health. 2021 Sep;198:348-357
pubmed: 34530237
Int Arch Med. 2011 Mar 01;4(1):10
pubmed: 21362196
PLoS Med. 2019 Apr 12;16(4):e1002783
pubmed: 30978179
J Am Coll Cardiol. 2018 May 15;71(19):e127-e248
pubmed: 29146535
J Epidemiol Glob Health. 2021 Dec;11(4):397-404
pubmed: 34734380
J Ment Health. 2020 Feb;29(1):45-51
pubmed: 30354901
JAMA Netw Open. 2022 Feb 1;5(2):e2147046
pubmed: 35113162
BMC Pregnancy Childbirth. 2022 Apr 20;22(1):342
pubmed: 35443652
Ann Glob Health. 2019 Mar 15;85(1):
pubmed: 30896134
Nicotine Tob Res. 2021 Nov 5;23(12):2019-2027
pubmed: 34291296
Implement Sci Commun. 2022 Aug 2;3(1):84
pubmed: 35918703
BMC Womens Health. 2023 Jan 2;23(1):3
pubmed: 36593476
BMC Pregnancy Childbirth. 2014 Feb 19;14:75
pubmed: 24552439
BMC Pregnancy Childbirth. 2019 Nov 27;19(1):448
pubmed: 31775681
BMJ Glob Health. 2022 May;7(5):
pubmed: 35537761
BMC Public Health. 2018 Nov 7;18(Suppl 3):1215
pubmed: 30400865
J Public Health (Oxf). 2022 Aug 25;44(3):595-605
pubmed: 33982123
Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27
pubmed: 29222373
J Clin Psychol. 2017 Sep;73(9):1076-1090
pubmed: 28195649
BMC Pregnancy Childbirth. 2022 Jan 27;22(1):71
pubmed: 35086491
Depress Res Treat. 2016;2016:4518979
pubmed: 27635258
PLoS One. 2015 Oct 13;10(10):e0140021
pubmed: 26461923

Auteurs

Ayoposi Ogboye (A)

mDoc Healthcare, Lagos, Nigeria ayoposi.ogboye@mymdoc.com.

Jonas Kofi Akpakli (JK)

mDoc Healthcare, Lagos, Nigeria.

Amira Iwuala (A)

mDoc Healthcare, Lagos, Nigeria.

Imo Etuk (I)

mDoc Healthcare, Lagos, Nigeria.

Kendra Njoku (K)

mDoc Healthcare, Lagos, Nigeria.

Stodia Jackson (S)

mDoc Healthcare, Lagos, Nigeria.

Ugo Okoli (U)

Jhpiego Corporation, Abuja, Nigeria.

Kathleen Hill (K)

Jhpiego Corporation, Abuja, Nigeria.

Victoria Omoera (V)

Lagos State Government Ministry of Health, Ikeja, Lagos, Nigeria.

Folashade Oludara (F)

Federal Capital Territory Health & Human Services Secretariat, Abuja, Nigeria.

Iniobong Ekong (I)

Federal Capital Territory Health & Human Services Secretariat, Abuja, Nigeria.

Nneka Mobisson (N)

mDoc Healthcare, Lagos, Nigeria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH